PREDISIN ( trimetazidine dihydrochloride) is a medicine used in the treatment of diseases of the cardiovascular system.It reduces the number of episodes of angina the need for nitrates, the noise in the ears, dizziness .Predisin as a metabolic modulator of myocardial cells provides their protection from ischemia, increases physical endurance , improves contractility in the left ventricle, lowers blood pressure difference. Predisin is prescribed for coronary heart disease in the complex therapy for the prevention of angina attacks and cochleovestibular disorders ischemic origin.
- Coronary heart disease
- Chorioretinal circulatory disorders with ischemic component
- Vestibulocochlear disoders (tinnitus and dizziness)
Warranty & expiration date
100% Original PREDISIN
Expiration date up to 12.2021
Predisin is produced in the form of pills. Main ingredient: trimetazidine dihydrochloride 35(mg)
Predisin is taken orally with eating. The daily dosage is 35 mg (one pill) 2 times a day. The duration of treatment is prescribed individually depending on the patient's condition.
Hypersensitivity to the components of the drug, renal failure and expressed violations of liver function, pregnancy, breast-feeding, children under the age of 18.
Nervous system: rigidity; headaches by type of migraine; tremor of extremities ; dizziness.
Digestive tract: vomiting; epigastric pain, discomfort; diarrheal syndrome; nausea; symptoms of dyspepsia.Skin reactions: itching; hives; skin rashes.
Cardiovascular system: frequent, uncontrolled flushes of blood to the face, redness of the cheeks;
form of orthostatic hypotension. Rarely asthenic manifestations.
Store in dry place at room temperature. Do not exceed storage temperature higher than 30 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Caution: Consult your physician if taking medications or have a medical condition.
Please connect with us if you need more information about PREDISIN